Showing results 3 to 9 of 9
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
Differential patterns of virological relapse and remission after discontinuation of tenofovir disoproxil fumarate or entecavir: results from a global, multi-ethnic cohort of patients with chronic hepatitis B virus infection (RETRACT-B Study) Proceeding/Conference:Poster presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology | 2021 | ||
Differential relapse patterns after discontinuation of entecavir vs tenofovir disoproxil fumarate in chronic hepatitis B Journal:Clinical Gastroenterology and Hepatology | 2022 | ||
EDP-514, a potent pangenotypic class ii hepatitis B virus core inhibitor, demonstrates significant HBV DNA and HBV RNA reductions in a phase 1b study in viremic, chronic hepatitis B infected patients Proceeding/Conference:Poster presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology | 2021 | ||
2020 | |||
2018 | |||
2023 | |||
2021 |